Camalots und Camalot Ultralights — recall A12/0595/16
EU Safety Gate (RAPEX) · Austria · 2016-05-20 · Serious risk
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Bei einem sehr hohen Prozentsatz der Produkte ist es möglich, dass die Achsen der Klemmgeräte nicht korrekt vernietet sind. Dies könnte dazu führen, dass das Klemmgerät nicht vollständig federnd ist oder bei Gebrauch auseinanderfällt. Infolgedessen könnte der Kletterer aus großer Höhe stürzen und schwere oder tödliche Verletzungen erleiden. Das Produkt entspricht nicht der Richtlinie für persönliche Schutzausrüstung.
Action taken by the authority
Type of economic operator taking notified measure
Manufacturer
Category of measure
Recall of the product from end users
Date of entry into force
13/04/2016
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): Camalots and Camalot Ultralights
Risk Description (original English): In a very high percentage of the products, it is possible that the axles of the camming devices are not correctly riveted. This could result in the camming device not being fully resilient or falling apart when used. As a consequence, the climber could fall from a height and sustain serious or fatal injuries.The product does not comply with the Personal Protective Equipment Directive.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.